rxlist.com (Byetta ) rxlist.com (Byduron ) extended release formulation Keywords Liraglutide Trade Names: Victoza & generic Pharmacology: GLP-1 analog mechanism of action is the same as exenatide Indications: an adjunct to diet and exercise to improve glycemic control in type 2 diabetes mellitus to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease Pharmacokinetics: once-daily injection Side Effects: Most common : nausea, diarrhea, vomiting (similar to exenatide) Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
The prevention of steatohepatitis development is well-documented, as shown by the LEAN-J study, in which liraglutide attained histological resolution in 39% of patients, compared to 9% in the control group (Eguchi et al
Insurance coverage for brand-name GLP-1 medications typically require prior authorization, meaning your provider must get approval from your insurance company before you can get the prescription
Never combine Retatrutide with other GLP-1 or GIP agonists like semaglutide, tirzepatide, liraglutide, or dulaglutide due to overlapping mechanisms and severe side effect risk
Nissen expects tirzepatide to soon join the pure GLP-1 RAs with an FDA-approved indication for weight loss in addition to diabetes, although it may meet the same payer reluctance around reimbursement for weight loss that the pure GLP-1 RAs have
While Semaglutide GLP-1 is not identical to GLP-1, its similarities deliver similar benefits